Clinical trial
Point-of-Care HIV Testing and Early Dolutegravir Use for Infants
NCT05393193 is registered in ClinicalTrials.gov with Harvard School of Public Health (HSPH) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Point-of-Care HIV Testing and Early Dolutegravir Use for Infants
- Lead sponsor
- Harvard School of Public Health (HSPH)
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- July 4, 2022
- Completion date
- December 31, 2026
- Enrollment
- 900 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv